Compare BioNano Genomics Inc (BNGO) vs Quantumscape Corp (QS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNano Genomics Inc vs Quantumscape Corp — how do they compare? BioNano Genomics Inc trades at $1.2 (market cap $13.66M), while Quantumscape Corp trades at $6.38 (market cap $3.90B). The key difference: Quantumscape Corp is far larger — about 285.5× BioNano Genomics Inc's market cap. Which is the better fit depends on your goals.
| BNGO | QS | |
|---|---|---|
Market Cap | $13.66M | $3.90B |
Sector | Health | Consumer Cyclical |
52-Week High | $4.92 | $18.44 |
52-Week Low | $1.06 | $4.89 |
Enterprise Value | $16.26M | $3.11B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About BioNano Genomics Inc
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Read more on BNGO →About Quantumscape Corp
QuantumScape Corp is engaged in the development of next-generation solid-state lithium-metal batteries for use in electric vehicles. It developed anode-less cell design, which delivers high energy density while lowering material costs and simplifying manufacturing.
Read more on QS →
